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Background
Transglutaminases (TGs) are ubiquitous calcium-dependent
acyl-transferases, catalysing post-translational protein modi-
fications. Among the family members, TG2 (or “tissue”
transglutaminase) acts as a multifunctional protein regulat-
ing cell processes, including autophagy [1].
TG2 is highly expressed in the nervous tissue and
reportedly involved in neurodegenerative disorders.
Indeed, the pathophysiology of these diseases includes
insoluble aggregate formation, and covalent cross-linking
of pathogenic proteins by TG2 has been suggested.
Another hallmark of neurodegeneration is dysregulated
autophagy, thus making the role played by TG2 in this
cellular process especially relevant. Interestingly, condi-
tions promoting TG2 activity, such as low GTP and high
calcium levels, associated with oxidative stress, occur in
neurodegeneration.
The present study aims to clarify the role of TG2 in
redox balance and autophagy. To this purpose, the expres-
sion levels of antioxidant enzymes and pro-autophagic
proteins were investigated in various brain regions and
liver of TG2-/- mice.
Materials and methods
Expression of antioxidant enzymes, namely superoxide
dismutase 1 and 2 (SOD1, SOD2), catalase (CAT) and
glutathione peroxidase 1 (GPX1), and autophagic pro-
teins (Beclin1, LC3 and AMBRA1) were evaluated by
Western blotting (WB) and immunohistochemistry in
selected brain areas (neocortex, hippocampus, brainstem,
and cerebellum) and liver of 12-month-old TG2-/- and
wild-type mice.
Results
WB and immunohistochemical data reveal altered
expression patterns of antioxidant enzymes in both liver
and brain tissues. Of particular interest is the statistically
significant decrease of CAT and SOD2 in the cerebel-
lum and hippocampus of TG2-/- mice, while unchanged
levels of these proteins are detected in the neocortex
and brainstem. In the knockout liver, even more dra-
matic reduction of CAT and SOD2 expression is found,
while SOD1 is intriguingly upregulated. Concerning the
effect of TG2 deletion on autophagy, Beclin1 is down-
regulated in the neocortex and hippocampus of knock-
out mice.
Conclusions
Overall, our data on TG2-/- mice support the involve-
ment of the transamidating enzyme in controlling redox
balance of different organs, and in regulating autophagic
flux [1-3]. The specific decrease in the peroxisomal
enzyme CAT and in the mitochondrial protein SOD2
emphasizes the role of these organelles in oxidative stress
management and their interplay in cell metabolism.
Moreover, region-based differences in the effect of TG2
deletion may reflect multiple functions related to the
organ, tissue and cell type.
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